ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

Institutions Required To Review For Bias under PHS Proposal

July 22, 1994

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003

New GAO Report Critical Of federal Effort Against Environmental Carcinogenesis

June 25, 1976

Senate Votes Down Attempt to Cut NCI Funds $100 Million

October 3, 1975

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014